Skip to Main Content

Lisa Fucito, PhD

Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry

Research Summary

Cigarette smoking and heavy alcohol consumption are the first and third preventable causes of death and disease in the U.S., respectively. Both also frequently co-occur with other modifiable health risk behaviors such as insufficient sleep and physical inactivity/poor nutrition. Despite these health risks, a substantial number of individuals are unable to successfully quit smoking or reduce their drinking. Current efficacious treatments have limitations: (1) not integrated with primary and/or specialty healthcare where most individuals who smoke and/or drink are treated; (2) do not address the multimorbidities that frequently accompany these behaviors; and (3) pose accessibility barriers. There is a need to identify effective integrated models that attenuate healthcare barriers as well as interventions that generalize across multiple negative health behaviors. Multiple health behavior change interventions have the potential to maximize health benefits and reduce health costs.

My research focuses on:

  1. Developing novel prevention and intervention strategies that promote multiple health behavior change;
  2. Using health feedback (e.g., biosensor data, biomarkers) to motivate health behavior change;
  3. Testing primary healthcare topics (e.g., sleep) as a "gateway" to addressing heavy alcohol consumption and smoking;
  4. Utilizing technology to assess and deliver interventions to reduce treatment access barriers;
  5. Identifying factors that optimize the efficacy of existing interventions;
  6. Examining the mechanisms through which these treatments bring about clinical change.

Specialized Terms: Treatments for tobacco and alcohol use; Moderators of treatment response; Risk behavior mechanisms; Sleep disturbance and substance use; Multiple health behavior change; M-health; Health feedback

Extensive Research Description

Current Research Projects:

Development of a Multimodal Mobile Sleep Intervention Using Wearable Technology to Reduce Heavy Drinking in Young Adults PI: Fucito. Funding: NIAAA R34AA026021. The current proposal will develop and test a mobile sleep/alcohol self-monitoring + sleep/alcohol data feedback intervention in 120 heavy-drinking young adults. The study will test different intervention components for improving sleep and substance in this population. The components include: 1) passive self-monitoring via sleep and alcohol biosensors, 2) active self-monitoring via mobile daily diaries, 3) computer-delivered sleep hygiene advice, and 4) personalized feedback about sleep and alcohol self-monitoring data.

Enhancing Tobacco Treatment for Yale Cancer Center Patients: A Pilot Test of an Embedded Pharmacist Model. PI: Fuchs, Fucito. Funding: NCI – C3i Initiative, P30CA016359-S. This service implementation project involves the implementation and evaluation of a novel, pharmacist-delivered intervention and a proactive, electronic outreach model to increase the number of cancer patients who are offered tobacco treatment and participate in treatment. The goal is to increase the number who are screened and treated for tobacco use across the Yale Cancer Center Network statewide.

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs PI: Toll; Yale Site PI: Fucito. Funding: NCI R01CA207229. The purpose of this study is to test a mobile tobacco intervention for promoting smoking cessation among smokers receiving lung cancer screening.

Contingency Management to Promote Smoking Abstinence in Cancer Patients. PI: Toll; Yale Site PI: Fucito. Funding: NCI R01CA251158. This project will conduct a randomized, controlled test of the effect of adding contingency management to standard smoking cessation treatment to enhance rates of smoking cessation for cancer patients before their cancer surgery.

Switching to a non-tobacco-based oral nicotine product among adult cigarette smokers: Exploring the roles of product characteristics and user history. Pilot PI: Fucito. Funding: FDA U54DA036151. The purpose of this study is to investigate the potential reduction in harm of switching from combustible smoking to new oral nicotine pouches in adult smokers. The study will examine changes in tobacco harm exposure from switching as well as factors that may influence the likelihood of switching such as nicotine concentration, flavor, and user characteristics.



Coauthors

Research Interests

Alcoholism; Behavior and Behavior Mechanisms; Sleep Initiation and Maintenance Disorders; Psychotherapy; Sleep; Sleep Wake Disorders; Tobacco; Smoking Cessation; Risk Reduction Behavior; Psychiatry and Psychology

Public Health Interests

Behavioral Health; Mental Health; Substance Use, Addiction

Selected Publications

Clinical Trials

ConditionsStudy Title
Addictive Behaviors; Tobacco Addiction; COVID-19 Inpatient; COVID-19 OutpatientReal-Time Surveillance of E-Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)
Addictive Behaviors; Mental Health & Behavioral Research; Tobacco AddictionSwitching to Potential Reduced Exposure Products in Adult Smokers (JUUL)
Alcohol AddictionSleep Intervention for Heavy Drinking Young Adults